Trial NC-HEM-16-6


Single Arm Study of Alxn1210 in Complement Inhibitor Treatment-Naïve Adult and Adolescent Patients With Atypical Hemolytic Uremic Syndrome (AHUS-311)

Type: Treatment
Phase: Phase III
Status: Not Open (Closed)
Treatments: Immunotherapy
Randomized: No
Defintions of terms and FAQ about clinical trials.
Trial Leaders/Researchers:  Caroline Piatek, M.D.
Other Trial Staff:  Ramona Lujan, Coordinator, Grace Facio, Coordinator, Christine Duran, Coordinator, Ibrahim Syed, Coordinator, Jubilee Acap, Coordinator, Laurie De Oliveira, Coordinator, Teresa Olea, Coordinator, Donna Fernando, Coordinator, Meena Ibrahim, D.M., Bartolo Santos, Coordinator, Peter Alexander, Coordinator, Kseniia Kulakova, D.M.

Staff may log in to see study documents.

Click here to see trial eligibility criteria and further details at ClinicalTrials.gov





For further information on a study, please contact the Clinical Investigation Support Office at (323) 865-0451, or clinical.trials@med.usc.edu.

To schedule a consultation with the hospital, please call our New Patient Referrals Office at (323) 865-3300.